“Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.”, Vaccine, vol. 36, no. 6, pp. 881-889, 2018.
, “Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.”, Vaccine, vol. 36, no. 11, pp. 1491-1499, 2018.
, “Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.”, J Infect Dis, vol. 210, no. 8, pp. 1270-4, 2014.
, “Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females.”, J Pediatric Infect Dis Soc, vol. 2, no. 1, pp. 7-14, 2013.
, “Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males.”, Clin Infect Dis, vol. 51, no. 10, pp. e76-81, 2010.
,